ArticleBritish journal of haematology2016

Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.

Maurizio Musso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.